Evidence map›Paper›PMID 29481616›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2019

Tobacco Use Prevalence and Smoking Cessation Pharmacotherapy Prescription Patterns Among Hospitalized Patients by Medical Specialty.

A Benjamin Srivastava, Alex T Ramsey, Leslie D McIntosh, Thomas C Bailey, Sherri L Fisher, Louis Fox, Mario Castro, Yinjiao Ma, Timothy B Baker, Li-Shiun Chen and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Pilot Trial of a Behavioral Economics-Informed Clinical Decision Support Alert to Improve Inpatient Tobacco Use Treatment Rates.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Underutilization of guideline-concordant smoking cessation treatments in surgical patients: Lessons from a learning health system.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2022
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

A Benjamin SrivastavaDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO.
Alex T RamseyDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO.
Leslie D McIntoshDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO.
Thomas C BaileyDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
Sherri L FisherDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO.
Louis FoxDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO.
Mario CastroDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
Yinjiao MaDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO.
Timothy B BakerDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Li-Shiun ChenDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO.
Laura J BierutDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO.
Washington University in St. Louis · USUniversity of Wisconsin–Madison · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Enhancing the Effectiveness of Varenicline Based Smoking Cessation TreatmentR01HL109031 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B, STEIN, JAMES H · 2011 to 2020
$17.5M
Washington University Career Development Program in Drug Abuse and AddictionK12DA041449 · NIDA · WASHINGTON UNIVERSITY · PI Laura J. Bierut, Patricia A Cavazos-Rehg · 2017 to 2026
$4.2M
Genetically Informed Smoking Cessation TrialR01DA038076 · NIDA · WASHINGTON UNIVERSITY · PI CHEN, LI-SHIUN · 2014 to 2018
$3.3M
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare VariantsR01DA036583 · NIDA · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2014 to 2017
$3.0M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NHLBI NIH HHS R01 HL109031NIDA NIH HHS K12 DA041449NIDA NIH HHS R01 DA036583NIDA NIH HHS R01 DA038076
6 · The paper itself

Abstract

introductionEffective smoking cessation medications are readily available but may be underutilized in hospital settings. In our large, tertiary care hospital, we aimed to (1) characterize patient tobacco use prevalence across medical specialties, (2) determine smoking cessation pharmacotherapy prescription variation across specialties, and (3) identify opportunities for improvement in practice.

methodsUsing electronic health records at Barnes Jewish Hospital, we gathered demographic data, admitting service, admission route, length of stay, self-reported tobacco use, and smoking cessation prescriptions over a 6-year period, from 2010 to 2016. We then compared tobacco use prevalence and smoking cessation prescriptions across medical specialties using a cross-sectional, retrospective design.

resultsPast 12-month tobacco use was reported by patients in 27.9% of inpatient admissions; prescriptions for smoking cessation pharmacotherapy were provided during 21.5% of these hospitalizations. The proportion of patients reporting tobacco use was highest in psychiatry (55.3%) and lowest in orthopedic surgery (17.1%). Psychiatric patients who reported tobacco use were most likely to receive pharmacotherapy (71.8% of admissions), and plastic surgery patients were least likely (4.7% of admissions). Compared with Caucasian tobacco users, African American patients who used tobacco products were less likely to receive smoking cessation medications (adjusted odds ratio [aOR] = 0.65; 95% confidence interval [CI] = 0.62 to 0.68).

conclusionsAmong hospitalized tobacco users, safe and cost-effective pharmacotherapies are under-prescribed. We identified substantial variation in prescribing practices across different medical specialties and demographic groups, suggesting the need for an electronic medical record protocol that facilitates consistent tobacco use cessation pharmacotherapy treatment. IMPLICATIONS: Tobacco use cessation pharmacotherapy is underutilized during hospitalization, and prescription rates vary greatly across medical specialties and patient characteristics. Hospitals may benefit from implementing policies and practices that standardize and automate the offer of smoking pharmacotherapy for all hospitalized patients who use tobacco.

Indexed as

Drug PrescriptionsHospitalizationAdolescentAdultAgedAged, 80 and overCross-Sectional StudiesDelivery of Health CareFemaleHumansMaleMedicineMiddle AgedPrevalenceRetrospective StudiesSmoking Cessation

Identifiers

PMID29481616
PMCPMC6468129
OpenAlexW2790733749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.